PENTIXAPHARM N
WKNA40AEG
SektorGesundheit
Index-
1,76€-0,03€
30.09.2025 20:44-1,79%
1,76€-0,03€
30.09.2025 20:44-1,79%
Eröffnung
1,784
Hoch
1,87
Tief
1,76
Umsatz
1.385,236
Marktkapitalisierung in Mio. (EUR)
44,88
Volatilität (30 Tage)
63,92 %
P/E Ratio
-
Dividende pro Aktie
0,00
Gewinn pro Aktie
-0,6912
Über Pentixapharm Holding AG
Firmensitz
Robert-Roessle-Strasse 10
13125, BERLIN
DE
Mitarbeitende
64
Streubesitz
56,73 %
Pentixapharm Holding AG is a Germany-based clinical-stage radiopharmaceutical development company. The Company focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. It is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Related Events